Immunocore Holdings Ltd

Healthcare · Biotechnology

29.60$ -0.4% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Immunocore Holdings Ltd (IMCR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,119 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IMCR
Line item	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	–	–	–	246	–	154	131	197	526	488	331	409	371	296	445	527	431	442	464	597	994	1,023	1,085	1,010	1,028	1,082	1,103	1,067	1,072	1,119
Current Assets	–	–	–	165	94	94	77	153	468	430	290	356	320	257	404	474	386	396	416	529	926	957	1,006	930	949	1,002	1,023	997	1,004	1,051
Cash	–	–	–	98	74	57	57	177	432	385	257	322	271	208	347	402	337	344	364	443	833	505	538	456	477	488	498	468	453	485
Cash & Short-Term Investments	124	–	–	98	74	57	57	177	432	385	257	322	271	208	347	402	337	344	364	443	833	860	901	820	837	883	892	864	845	880
Receivables	–	–	–	66	31	0.6	0.1	2.1	36	31	1.7	34	49	24	26	57	48	51	50	61	58	60	64	83	63	70	76	74	81	95
Inventory	–	–	–	-4.5	–	–	-5.5	-6.5	-7.0	-9.9	-8.0	-7.7	0.7	0.5	0.9	0.7	0.9	1.9	1.9	4.5	4.2	3.5	4.5	5.4	6.8	5.5	5.7	6.7	8.3	7.8
Property, Plant & Equipment	–	–	–	55	50	50	45	37	35	33	33	32	30	29	31	32	–	33	34	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	–	–	–	–	–	–	16	–	–	–	–	–	–	–	0.4	0.0	0.4	0.4	1.6	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	-57	–	–	226	-15	120	115	142	187	181	129	176	156	131	150	188	156	164	173	228	634	664	707	649	650	694	706	686	678	700
Current Liabilities	–	–	–	112	44	44	48	55	75	76	55	83	70	65	77	101	85	93	98	139	155	185	266	212	149	170	170	247	240	235
Short-Term Debt	–	–	–	28	–	2.1	2.1	13	3.2	3.0	1.9	1.7	1.7	1.4	1.6	1.9	1.6	2.5	2.3	1.4	1.2	1.4	49	1.5	1.7	1.8	1.9	2.0	2.0	1.9
Accounts Payable	–	–	–	21	4.4	4.4	5.8	7.9	7.1	8.2	4.5	10	8.0	6.6	10	14	9.3	14	11	18	16	20	20	25	29	24	23	24	30	26
Long-Term Debt	–	–	–	–	–	–	–	37	36	36	37	37	38	42	46	40	39	37	38	48	438	438	390	391	392	392	393	393	394	394
Shareholders' Equity	57	–	–	20	15	33	16	55	339	307	202	232	215	165	295	339	274	278	291	369	360	359	378	361	378	388	397	381	394	420
Retained Earnings	–	–	–	-370	-312	-312	-331	-350	-523	-569	-442	-652	-655	-242	-236	-689	-278	-293	-290	-745	-769	-781	-772	-796	-791	-801	-801	-831	-818	-819
Shares Outstanding	214	214	220	27	27	27	32	38	38	44	44	44	44	44	51	47	48	49	54	49	50	50	53	50	52	50	50	50	53	51

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings